BMY

Bristol-Myers Squibb Company is a global biopharmaceutical leader focused on the discovery, development, and delivery of innovative medicines for patients with serious diseases. The company maintains a diversified portfolio with a strong emphasis on oncology, hematology, immunology, and cardiovascular therapeutic areas. By integrating internal research and development with strategic acquisitions, the firm aims to address high unmet medical needs in complex disease states.